Cases filed in New Jersey
Cases 11 - 20 of 126
NEUROCRINE BIOSCIENCES, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 3:2022cv05830
Defendant: ZYDUS LIFESCIENCES LIMITED, ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS WORLDWIDE DMCC and others
Plaintiff: NEUROCRINE BIOSCIENCES, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
SALIX PHARMACEUTICALS, INC. et al v. ZYDUS PHARMACEUTICALS (USA), INC. et al
as 2:2022cv05589
Plaintiff: SALIX PHARMACEUTICALS, INC., SALIX PHARMACEUTICALS, LTD. and BAUSCH HEALTH COMPANIES INC.
Defendant: ZYDUS PHARMACEUTICALS (USA), INC., ZYDUS WORLDWIDE DMCC and ZYDUS LIFESCIENCES LIMITED
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ASTELLAS PHARMA INC. et al v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 2:2022cv04499
Plaintiff: ASTELLAS PHARMA INC., ASTELLAS US LLC, ASTELLAS PHARMA US, INC. and others
Defendant: ZYDUS PHARMACEUTICALS (USA) INC. and ZYDUS LIFESCIENCES LTD
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
MYLAN INC. et al v. SOMAXON PHARMACEUTICALS, INC. et al We have downloadable decisions or orders for this case
as 2:2022cv03944
Petitioner: MYLAN INC. and MYLAN PHARMACEUTICALS INC.,
Plaintiff: SOMAXON PHARMACEUTICALS, INC. and PROCOM ONE INC.
Respondent: Currax Pharmaceuticals LLC, Currax Holdings LLC and Currax Holdings USA LLC
Interested Party: PAR PHARMACEUTICAL INC, ACTAVIS ELIZABETH LLC, ACTAVIS INC. and others
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
ARAGON PHARMACEUTICALS, INC. et al v. ZYDUS WORLDWIDE DMCC et al
as 2:2022cv02964
Plaintiff: ARAGON PHARMACEUTICALS, INC., JANSSEN BIOTECH, INC. and SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH
Defendant: ZYDUS WORLDWIDE DMCC, ZYDUS PHARMACEUTICALS (USA) INC. and ZYDUS LIFESCIENCES LIMITED
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
NEUROCRINE BIOSCIENCES, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 3:2022cv01882
Plaintiff: NEUROCRINE BIOSCIENCES, INC.
Defendant: ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS WORLDWIDE DMCC, ZYDUS HEALTHCARE (USA) LLC and others
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
NEUROCRINE BIOSCIENCES, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 1:2022cv01882
Plaintiff: NEUROCRINE BIOSCIENCES, INC.
Defendant: ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS WORLDWIDE DMCC, ZYDUS HEALTHCARE (USA) LLC and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
FRESENIUS KABI USA, LLC v. ZYDUS PHARMACEUTICALS (USA) INC.
as 3:2022cv01702
Plaintiff: FRESENIUS KABI USA, LLC
Defendant: ZYDUS PHARMACEUTICALS (USA) INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 2:2022cv01592
Plaintiff: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Defendant: ZYDUS PHARMACEUTICALS (USA) INC. and CADILA HEALTHCARE LIMITED
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 3:2022cv01592
Plaintiff: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Defendant: ZYDUS PHARMACEUTICALS (USA) INC. and CADILA HEALTHCARE LIMITED
Cause Of Action: 35 U.S.C. § 271 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?